ArticleACG case reports journal2025
The Persistent Wound: Plasmablastic Lymphoma in a Perianal Fistula.
Article in ACG case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Giant Intra-Abdominal Plasmablastic Neoplasm Favoring Lymphoma Mimicking an Exacerbation of Severe Fistulizing Crohn's Disease: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmablastic lymphoma is an aggressive subtype of diffuse large B-cell lymphoma associated with immunosuppression, particularly in HIV-positive patients. Although rare in HIV-negative individuals, patients with Crohn's disease experience immune dysregulation due to chronic immunosuppression that can predispose them to plasmablastic lymphoma. We present a case of a 54-year-old man with ileocolonic and perianal fistulizing Crohn's disease who developed plasmablastic lymphoma. This case emphasizes the importance of early recognition of plasmablastic lymphoma in patients undergoing chronic immunosuppressive treatment of Crohn's disease, as early diagnosis and timely intervention are crucial for improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.